{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:01:19Z","timestamp":1794949279565,"version":"4.9.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The emergence of multidrug-resistant (MDR) strains of genital pathogens, notably <jats:italic>Mycoplasma genitalium<\/jats:italic> and <jats:italic>Ureaplasma<\/jats:italic> spp., constitutes a significant global threat today. The present study aimed to evaluate the prevalence and trend of changes in MDR <jats:italic>mycoplasma<\/jats:italic> and <jats:italic>ureaplasma<\/jats:italic> strains.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An exhaustive search was performed across the ISI Web of Science, PubMed, Scopus, ScienceDirect, and Google Scholar databases to accumulate relevant studies without restrictions until April 2023. We used event rate and corresponding 95% confidence intervals to determine the frequency of resistance-related mutations and examine the trend of antibiotic resistance changes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The data from 27 studies, including 24,662 patients across 14 countries, were evaluated. Out of the total studies, 20 focused on <jats:italic>M. genitalium<\/jats:italic> infections, and five on <jats:italic>Ureaplasma<\/jats:italic> spp. The frequency of resistance-associated mutations to macrolides, tetracyclines, and fluoroquinolones in clinical strains of <jats:italic>M. genitalium<\/jats:italic> was 43.5%, 13.1%, and 18.6%, respectively. The prevalence of <jats:italic>M. genitalium<\/jats:italic> strains with double resistance and MDR was 11.0% and 17.4%, respectively. The incidence of both double-drug-resistant and MDR strains was higher in the World Health Organization (WHO) Western Pacific Region than in European and American populations. For <jats:italic>Ureaplasma<\/jats:italic> strains, resistance-associated mutations to macrolides, tetracyclines, and fluoroquinolones were 40.8%, 25.7%, and 90.3%, respectively. The rate of antibiotic resistance was higher in the African population compared to the European and WHO Western Pacific Regions. The rate of MDR <jats:italic>Ureaplasma<\/jats:italic> infections was 13.2%, with a higher incidence in the African population compared to the WHO Western Pacific and European regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The proliferation and spread of MDR <jats:italic>Mycoplasma<\/jats:italic> and <jats:italic>Ureaplasma<\/jats:italic> strains present a significant public health challenge. The situation is indeed alarming, and the rising trend of MDR <jats:italic>M. genitalium<\/jats:italic> and MDR <jats:italic>Ureaplasma<\/jats:italic> infections suggests that therapies involving macrolides and fluoroquinolones may become less effective.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12941-023-00627-6","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T14:03:00Z","timestamp":1691676180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Mohammad","family":"Abavisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Keikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"627_CR1","unstructured":"Organization WH. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. 2022."},{"issue":"6","key":"627_CR2","doi-asserted-by":"crossref","first-page":"e02560","DOI":"10.1128\/AAC.02560-19","volume":"64","author":"T Yang","year":"2020","unstructured":"Yang T, Pan L, Wu N, Wang L, Liu Z, Kong Y, Ruan Z, Xie X, Zhang J. Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying quinolone resistance. Antimicrob Agents Chemother. 2020;64(6):e02560\u201302519.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8233","key":"627_CR3","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(81)92461-2","volume":"317","author":"J Tully","year":"1981","unstructured":"Tully J, Cole R, Taylor-Robinson D, Rose D. A newly discovered mycoplasma in the human urogenital tract. The Lancet. 1981;317(8233):1288\u201391.","journal-title":"The Lancet"},{"issue":"4","key":"627_CR4","doi-asserted-by":"crossref","first-page":"105911","DOI":"10.1016\/j.ijantimicag.2020.105911","volume":"55","author":"TE van der Schalk","year":"2020","unstructured":"van der Schalk TE, Braam JF, Kusters JG. Molecular basis of antimicrobial resistance in Mycoplasma genitalium. Int J Antimicrob Agents. 2020;55(4):105911.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"627_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","volume":"61","author":"R Lis","year":"2015","unstructured":"Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418\u201326.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"627_CR6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","volume":"24","author":"D Taylor-Robinson","year":"2011","unstructured":"Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24(3):498\u2013514.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"627_CR7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0956462416648585","volume":"27","author":"PJ Horner","year":"2016","unstructured":"Horner PJ, Blee K, Falk L, van der Meijden W, Moi H. 2016 european guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27(11):928\u201337.","journal-title":"Int J STD AIDS"},{"issue":"12","key":"627_CR8","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/599033","volume":"48","author":"LA Mena","year":"2009","unstructured":"Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium\u2013positive urethritis in men. Clin Infect Dis. 2009;48(12):1649\u201354.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"627_CR9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jdv.13849","volume":"30","author":"JS Jensen","year":"2016","unstructured":"Jensen JS, Cusini M, Gomberg M, Moi H. 2016 european guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30(10):1650\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"627_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/OLQ.0000000000001132","volume":"47","author":"LE Manhart","year":"2020","unstructured":"Manhart LE, Jensen JS. Quinolone Resistance\u2013Associated mutations in Mycoplasma genitalium: not ready for Prime Time. Sex Transm Dis. 2020;47(3):199.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"627_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10156-011-0329-8","volume":"18","author":"M Terada","year":"2012","unstructured":"Terada M, Ohki E, Yamagishi Y, Izumi K, Mikamo H. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. J Infect Chemother. 2012;18(3):313\u20137.","journal-title":"J Infect Chemother"},{"issue":"10","key":"627_CR12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0956462413502008","volume":"24","author":"DL Couldwell","year":"2013","unstructured":"Couldwell DL, Tagg KA, Jeoffreys NJ, Gilbert GL. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS. 2013;24(10):822\u20138.","journal-title":"Int J STD AIDS"},{"issue":"8","key":"627_CR13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/ciu1162","volume":"60","author":"M Bissessor","year":"2015","unstructured":"Bissessor M, Tabrizi SN, Twin J, Abdo H, Fairley CK, Chen MY, Vodstrcil LA, Jensen JS, Hocking JS, Garland SM. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium\u2013infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015;60(8):1228\u201336.","journal-title":"Clin Infect Dis"},{"issue":"suppl2","key":"627_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jix132","volume":"216","author":"CS Bradshaw","year":"2017","unstructured":"Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment. J Infect Dis. 2017;216(suppl2):412\u2013S419.","journal-title":"J Infect Dis"},{"issue":"11","key":"627_CR15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","volume":"20","author":"DA Machalek","year":"2020","unstructured":"Machalek DA, Tao Y, Shilling H, Jensen JS, Unemo M, Murray G, Chow EP, Low N, Garland SM, Vodstrcil LA. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20(11):1302\u201314.","journal-title":"Lancet Infect Dis"},{"key":"627_CR16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10096-017-2969-9","volume":"36","author":"J Braam","year":"2017","unstructured":"Braam J, van Dommelen L, Henquet C, van de Bovenkamp J, Kusters J. Multidrug-resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis. 2017;36:1565\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"627_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-12-88","volume":"12","author":"V Paralanov","year":"2012","unstructured":"Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Meth\u00e9 BA, Inman J, Yooseph S, Xiao L, Cassell GH. Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvumstrains. BMC Microbiol. 2012;12(1):1\u201320.","journal-title":"BMC Microbiol"},{"issue":"4","key":"627_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CMR.18.4.757-789.2005","volume":"18","author":"KB Waites","year":"2005","unstructured":"Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18(4):757\u201389.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"627_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ogc.2014.08.010","volume":"41","author":"AP Murtha","year":"2014","unstructured":"Murtha AP, Edwards JM. The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin. 2014;41(4):615\u201327.","journal-title":"Obstet Gynecol Clin"},{"issue":"2","key":"627_CR20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3892\/etm.2016.3409","volume":"12","author":"X Zhu","year":"2016","unstructured":"Zhu X, Li M, Cao H, Yang X, Zhang C. Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the semen of male outpatients with reproductive disorders. Experimental and Therapeutic Medicine. 2016;12(2):1165\u201370.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"627_CR21","doi-asserted-by":"crossref","unstructured":"Waites KB, Schelonka RL, Xiao L, Grigsby PL, Novy MJ. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Seminars in fetal and neonatal medicine: 2009: Elsevier; 2009: 190\u20139.","DOI":"10.1016\/j.siny.2008.11.009"},{"key":"627_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-171","volume":"14","author":"MJ Redelinghuys","year":"2014","unstructured":"Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard HA, Kock MM. Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women. BMC Infect Dis. 2014;14:1\u20136.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"627_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/jclinpath-2014-202248","volume":"67","author":"T Song","year":"2014","unstructured":"Song T, Ye A, Xie X, Huang J, Ruan Z, Kong Y, Song J, Wang Y, Chen J, Zhang J. Epidemiological investigation and antimicrobial susceptibility analysis of ureaplasma species and Mycoplasma hominis in outpatients with genital manifestations. J Clin Pathol. 2014;67(9):817\u201320.","journal-title":"J Clin Pathol"},{"issue":"2","key":"627_CR24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/AAC.00960-07","volume":"52","author":"S D\u00e9grange","year":"2008","unstructured":"D\u00e9grange S, Renaudin H, Charron A, B\u00e9b\u00e9ar C, B\u00e9b\u00e9ar C. Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet (M)-positive isolates of M. hominis susceptible to tetracyclines. Antimicrob Agents Chemother. 2008;52(2):742\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"627_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/AAC.47.1.161-165.2003","volume":"47","author":"KB Waites","year":"2003","unstructured":"Waites KB, Crabb DM, Bing X, Duffy LB. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003;47(1):161\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"627_CR26","doi-asserted-by":"crossref","first-page":"W","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W\u201365.","journal-title":"Ann Intern Med"},{"issue":"2","key":"627_CR27","doi-asserted-by":"crossref","first-page":"115854","DOI":"10.1016\/j.diagmicrobio.2022.115854","volume":"105","author":"L Li","year":"2023","unstructured":"Li L, Yuan Y, He W, Zheng L, Wang Q. Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China. Diagn Microbiol Infect Dis. 2023;105(2):115854.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"627_CR28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/OLQ.0000000000000631","volume":"44","author":"M-J Barber\u00e1","year":"2017","unstructured":"Barber\u00e1 M-J, Fern\u00e1ndez-Huerta M, Jensen J-S, Caballero E, Andreu A. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance. Sex Transm Dis. 2017;44(8):457\u201362.","journal-title":"Sex Transm Dis"},{"key":"627_CR29","doi-asserted-by":"crossref","unstructured":"Xiao L, Geisler WM, Waites KB, Aaron KJ, Dionne-Odom JA. Lb3. 260 Multidrug resistant mycoplasma genitalium in hiv-infected men who have sex with men (MSM) in the united states. In.: BMJ Publishing Group Ltd; 2017.","DOI":"10.1136\/sextrans-2017-053264.495"},{"issue":"8","key":"627_CR30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3390\/antibiotics10080962","volume":"10","author":"R Dumke","year":"2021","unstructured":"Dumke R, Spornraft-Ragaller P. Antibiotic resistance and genotypes of Mycoplasma genitalium during a resistance-guided treatment regime in a german university hospital. Antibiotics. 2021;10(8):962.","journal-title":"Antibiotics"},{"issue":"5","key":"627_CR31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/cid\/cix853","volume":"66","author":"J Dionne-Odom","year":"2018","unstructured":"Dionne-Odom J, Geisler WM, Aaron KJ, Waites KB, Westfall AO, Van Der Pol B, Xiao L. High prevalence of multidrug-resistant Mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama. Clin Infect Dis. 2018;66(5):796\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"627_CR32","doi-asserted-by":"crossref","first-page":"e0198355","DOI":"10.1371\/journal.pone.0198355","volume":"13","author":"R Hamasuna","year":"2018","unstructured":"Hamasuna R, Le PT, Kutsuna S, Furubayashi K, Matsumoto M, Ohmagari N, Fujimoto N, Matsumoto T, Jensen JS. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. PLoS ONE. 2018;13(6):e0198355.","journal-title":"PLoS ONE"},{"issue":"4","key":"627_CR33","doi-asserted-by":"crossref","first-page":"e0175763","DOI":"10.1371\/journal.pone.0175763","volume":"12","author":"E Shipitsyna","year":"2017","unstructured":"Shipitsyna E, Rumyantseva T, Golparian D, Khayrullina G, Lagos AC, Edelstein I, Joers K, Jensen JS, Savicheva A, Rudneva N. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia. PLoS ONE. 2017;12(4):e0175763.","journal-title":"PLoS ONE"},{"issue":"4","key":"627_CR34","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/OLQ.0000000000000940","volume":"46","author":"V Mulligan","year":"2019","unstructured":"Mulligan V, Lynagh Y, Clarke S, Unemo M, Crowley B. Prevalence, macrolide resistance, and fluoroquinolone resistance in Mycoplasma genitalium in men who have sex with men attending an sexually transmitted disease clinic in Dublin, Ireland in 2017\u20132018. Sex Transm Dis. 2019;46(4):e35\u20137.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"627_CR35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/OLQ.0000000000000891","volume":"46","author":"L Xiao","year":"2019","unstructured":"Xiao L, Waites KB, Van Der Pol B, Aaron KJ, Hook EW III, Geisler WM. Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-associated mutations in heterosexual african american couples in Alabama. Sex Transm Dis. 2019;46(1):18.","journal-title":"Sex Transm Dis"},{"key":"627_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-020-0681-5","volume":"9","author":"S Boujemaa","year":"2020","unstructured":"Boujemaa S, Mlik B, Ben Allaya A, Mardassi H, Ben Abdelmoumen Mardassi B. Spread of multidrug resistance among Ureaplasma serovars, Tunisia. Antimicrob Resist Infect Control. 2020;9:1\u201310.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"627_CR37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/civ898","volume":"62","author":"T Deguchi","year":"2016","unstructured":"Deguchi T, Kikuchi M, Yasuda M, Ito S. Multidrug-resistant Mycoplasma genitalium is increasing. Clin Infect Dis. 2016;62(3):405\u20136.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"627_CR38","doi-asserted-by":"crossref","first-page":"e066368","DOI":"10.1136\/bmjopen-2022-066368","volume":"12","author":"JF Braam","year":"2022","unstructured":"Braam JF, Zondag HC, van Dam AP, de Vries HJ, Vergunst C, Hetem D, van der Loeff MFS, Bruisten SM. Prevalence of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium among clients of two sexual health centres in the Netherlands: a cross-sectional study. BMJ open. 2022;12(12):e066368.","journal-title":"BMJ open"},{"key":"627_CR39","doi-asserted-by":"crossref","first-page":"724935","DOI":"10.3389\/fmicb.2021.724935","volume":"12","author":"H Ma","year":"2021","unstructured":"Ma H, Zhang X, Shi X, Zhang J, Zhou Y. Phenotypic antimicrobial susceptibility and genotypic characterization of clinical ureaplasma isolates circulating in Shanghai, China. Front Microbiol. 2021;12:724935.","journal-title":"Front Microbiol"},{"key":"627_CR40","unstructured":"Gamova N. Drug sensitivity of Ureaplasma urealyticum, persisting in patients with chronic inflammatory diseases of the urogenital tract. Zh Mikrobiol Epidemiol Immunobiol 2003(4):81\u20135."},{"key":"627_CR41","doi-asserted-by":"crossref","unstructured":"Xiao L, Totten AH, Crabb DM, Atkinson TP, Waites KB. Antimicrobial susceptibilities and mechanisms of resistance of commensal and invasive Mycoplasma salivarium isolates. Front Microbiol 2022:2677.","DOI":"10.3389\/fmicb.2022.914464"},{"issue":"3","key":"627_CR42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5336\/jcog.2020-76299","volume":"30","author":"\u0130 BIYIK","year":"2020","unstructured":"BIYIK \u0130, KESK\u0130N N, G\u00dcLCAN A, Onur \u0130, ERTEN \u00d6. Coinfection of Ureaplasma urealyticum\/Mycoplasma hominis in HPV positive women: frequency, risk factors and multidrug resistance. J Clin Obstet Gynecol. 2020;30(3):92\u20139.","journal-title":"J Clin Obstet Gynecol"},{"issue":"1","key":"627_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/sextrans-2017-053164","volume":"94","author":"R Pitt","year":"2018","unstructured":"Pitt R, Fifer H, Woodford N, Alexander S. Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services in England. Sex Transm Infect. 2018;94(1):9\u201313.","journal-title":"Sex Transm Infect"},{"issue":"6","key":"627_CR44","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3201\/eid2106.142013","volume":"21","author":"T Deguchi","year":"2015","unstructured":"Deguchi T, Yasuda M, Horie K, Seike K, Kikuchi M, Mizutani K, Tsuchiya T, Yokoi S, Nakano M, Hoshina S. Drug resistance\u2013associated mutations in Mycoplasma genitalium in female sex workers, Japan. Emerg Infect Dis. 2015;21(6):1062.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"627_CR45","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3201\/eid2209.160446","volume":"22","author":"C Le Roy","year":"2016","unstructured":"Le Roy C, H\u00e9nin N, Pereyre S, Bebear C. Fluoroquinolone-resistant Mycoplasma genitalium, southwestern France. Emerg Infect Dis. 2016;22(9):1677.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"627_CR46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3201\/eid2305.161745","volume":"23","author":"GL Murray","year":"2017","unstructured":"Murray GL, Bradshaw CS, Bissessor M, Danielewski J, Garland SM, Jensen JS, Fairley CK, Tabrizi SN. Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium. Emerg Infect Dis. 2017;23(5):809.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"627_CR47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/09564624211070704","volume":"33","author":"I De Baetselier","year":"2022","unstructured":"De Baetselier I, Vuylsteke B, Reyniers T, Smet H, Van den Bossche D, Kenyon C, Crucitti T. Worryingly high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium among men who have sex with men with recurrent sexually transmitted infections. Int J STD AIDS. 2022;33(4):385\u201390.","journal-title":"Int J STD AIDS"},{"key":"627_CR48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10096-020-04061-w","volume":"40","author":"R Nijhuis","year":"2021","unstructured":"Nijhuis R, Duinsbergen R, Pol A, Godschalk P. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands. Eur J Clin Microbiol Infect Dis. 2021;40:591\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"627_CR49","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/jac\/dku164","volume":"69","author":"M Kikuchi","year":"2014","unstructured":"Kikuchi M, Ito S, Yasuda M, Tsuchiya T, Hatazaki K, Takanashi M, Ezaki T, Deguchi T. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother. 2014;69(9):2376\u201382.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"627_CR50","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/JCM.00495-13","volume":"51","author":"KA Tagg","year":"2013","unstructured":"Tagg KA, Jeoffreys NJ, Couldwell DL, Donald JA, Gilbert GL. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol. 2013;51(7):2245\u20139.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"627_CR51","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/pathogens12030496","volume":"12","author":"IA Edelstein","year":"2023","unstructured":"Edelstein IA, Guschin AE, Romanov AV, Negasheva ES, Kozlov RS. Genetic determinants of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium and their prevalence in Moscow, Russia. Pathogens. 2023;12(3):496.","journal-title":"Pathogens"},{"issue":"3","key":"627_CR52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0956462419890737","volume":"31","author":"M Fern\u00e1ndez-Huerta","year":"2020","unstructured":"Fern\u00e1ndez-Huerta M, Barber\u00e1 MJ, Serra-Pladevall J, Esperalba J, Mart\u00ednez-G\u00f3mez X, Centeno C, Pich OQ, Pumarola T, Espasa M. Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review. Int J STD AIDS. 2020;31(3):190\u20137.","journal-title":"Int J STD AIDS"},{"issue":"9","key":"627_CR53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.medmal.2012.05.006","volume":"42","author":"C Cazanave","year":"2012","unstructured":"Cazanave C, Manhart L, B\u00e9b\u00e9ar C. Mycoplasma genitalium, an emerging sexually transmitted pathogen. M\u00e9decine et maladies infectieuses. 2012;42(9):381\u201392.","journal-title":"M\u00e9decine et maladies infectieuses"},{"issue":"3","key":"627_CR54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005054880109","volume":"5","author":"C B\u00e9b\u00e9ar","year":"2005","unstructured":"B\u00e9b\u00e9ar C, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets-Infectious Disorders. 2005;5(3):263\u201371.","journal-title":"Curr Drug Targets-Infectious Disorders"},{"issue":"12","key":"627_CR55","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1086\/593188","volume":"47","author":"JS Jensen","year":"2008","unstructured":"Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium\u2013positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008;47(12):1546\u201353.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"627_CR56","doi-asserted-by":"crossref","first-page":"e0162924","DOI":"10.1371\/journal.pone.0162924","volume":"11","author":"BA Mondeja","year":"2016","unstructured":"Mondeja BA, Rodr\u00edguez NM, Barroto B, Blanco O, Jensen JS. Antimicrobial susceptibility patterns of recent cuban Mycoplasma genitalium isolates determined by a modified cell-culture-based method. PLoS ONE. 2016;11(9):e0162924.","journal-title":"PLoS ONE"},{"issue":"1","key":"627_CR57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/sextrans-2016-053060","volume":"94","author":"P Horner","year":"2018","unstructured":"Horner P, Ingle SM, Garrett F, Blee K, Kong F, Muir P, Moi H. Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis. Sex Transm Infect. 2018;94(1):14\u201320.","journal-title":"Sex Transm Infect"},{"key":"627_CR58","doi-asserted-by":"crossref","unstructured":"Sethi S, Zaman K, Jain N. Mycoplasma genitalium infections: current treatment options and resistance issues. Infect drug Resist 2017:283\u201392.","DOI":"10.2147\/IDR.S105469"},{"issue":"9","key":"627_CR59","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jac\/dkv136","volume":"70","author":"R Nijhuis","year":"2015","unstructured":"Nijhuis R, Severs T, Van der Vegt D, Van Zwet A, Kusters J. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. J Antimicrob Chemother. 2015;70(9):2515\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"627_CR60","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/cid\/civ644","volume":"61","author":"A Lau","year":"2015","unstructured":"Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY, Hocking JS. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1389\u201399.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"627_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0781-7","volume":"15","author":"A Guschin","year":"2015","unstructured":"Guschin A, Ryzhikh P, Rumyantseva T, Gomberg M, Unemo M. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect Dis. 2015;15(1):1\u20137.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"627_CR62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3201\/eid2504.181258","volume":"25","author":"TR Read","year":"2019","unstructured":"Read TR, Murray GL, Danielewski JA, Fairley CK, Doyle M, Worthington K, Su J, Mokany E, Tan L, Lee D. Symptoms, sites, and significance of Mycoplasma genitalium in men who have sex with men. Emerg Infect Dis. 2019;25(4):719.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"627_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2892-9","volume":"18","author":"MJ Day","year":"2018","unstructured":"Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ, Unemo M. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 european countries, 2016. BMC Infect Dis. 2018;18(1):1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"627_CR64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1099\/jmm.0.000885","volume":"68","author":"C Kenyon","year":"2019","unstructured":"Kenyon C. Prevalence of macrolide resistance in Treponema pallidum is associated with macrolide consumption. J Med Microbiol. 2019;68(2):119\u201323.","journal-title":"J Med Microbiol"},{"issue":"1","key":"627_CR65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/eri.09.113","volume":"8","author":"L Boyanova","year":"2010","unstructured":"Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti-Infective Therapy. 2010;8(1):59\u201370.","journal-title":"Expert Rev Anti-Infective Therapy"},{"issue":"2","key":"627_CR66","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jksus.2019.11.015","volume":"32","author":"S Quaik","year":"2020","unstructured":"Quaik S, Embrandiri A, Ravindran B, Hossain K, Al-Dhabi NA, Arasu MV, Ignacimuthu S, Ismail N. Veterinary antibiotics in animal manure and manure laden soil: scenario and challenges in asian countries. J King Saud University-Science. 2020;32(2):1300\u20135.","journal-title":"J King Saud University-Science"},{"issue":"7","key":"627_CR67","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","volume":"14","author":"T Wi","year":"2017","unstructured":"Wi T, Lahra MM, Ndowa F, Bala M, Dillon J-AR, Ramon-Pardo P, Eremin SR, Bolan G, Unemo M. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 2017;14(7):e1002344.","journal-title":"PLoS Med"},{"key":"627_CR68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s15010-012-0257-2","volume":"40","author":"A Dalhoff","year":"2012","unstructured":"Dalhoff A. Resistance surveillance studies: a multifaceted problem\u2014the fluoroquinolone example. Infection. 2012;40:239\u201362.","journal-title":"Infection"},{"issue":"8","key":"627_CR69","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3201\/eid2608.191806","volume":"26","author":"D Durukan","year":"2020","unstructured":"Durukan D, Doyle M, Murray G, Bodiyabadu K, Vodstrcil L, Chow EP, Jensen JS, Fairley CK, Aguirre I, Bradshaw CS. Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium. Emerg Infect Dis. 2020;26(8):1870.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"627_CR70","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10156-012-0392-9","volume":"18","author":"S Ito","year":"2012","unstructured":"Ito S, Yasuda M, Seike K, Sugawara T, Tsuchiya T, Yokoi S, Nakano M, Deguchi T. Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J Infect Chemother. 2012;18(3):414\u20138.","journal-title":"J Infect Chemother"},{"issue":"3","key":"627_CR71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","volume":"14","author":"M Unemo","year":"2017","unstructured":"Unemo M, Jensen JS. Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Reviews Urol. 2017;14(3):139\u201352.","journal-title":"Nat Reviews Urol"},{"key":"627_CR72","doi-asserted-by":"crossref","unstructured":"Doyle M, Vodstrcil LA, Plummer EL, Aguirre I, Fairley CK, Bradshaw CS. Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance. Open Forum Infectious Diseases: 2020: Oxford University Press US; 2020: ofaa291.","DOI":"10.1093\/ofid\/ofaa291"},{"issue":"4","key":"627_CR73","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/dkaa538","volume":"76","author":"MH Ahmadi","year":"2021","unstructured":"Ahmadi MH. Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: a systematic review and meta-analysis. J Antimicrob Chemother. 2021;76(4):865\u201375.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"627_CR74","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/jdv.15146","volume":"32","author":"P Horner","year":"2018","unstructured":"Horner P, Donders G, Cusini M, Gomberg M, Jensen J, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?\u2013a position statement from the european STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32(11):1845\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"S1","key":"627_CR75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1601-0825.1997.tb00348.x","volume":"3","author":"I Lamster","year":"1997","unstructured":"Lamster I, Grbic J, Bucklan R, Mitchell-Lewis D, Reynolds H, Zambon J. Epidemiology and diagnosis of HIV\u2010associated periodontal diseases. Oral Dis. 1997;3(S1):141\u2013S148.","journal-title":"Oral Dis"},{"issue":"8","key":"627_CR76","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jop.12568","volume":"46","author":"H Mizuki","year":"2017","unstructured":"Mizuki H, Abe R, Kogi S, Mikami T. Immunohistochemical detection of Mycoplasma salivarium in oral lichen planus tissue. J Oral Pathol Med. 2017;46(8):649\u201356.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"627_CR77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2016.05.018","volume":"86","author":"M B\u00fcchsel","year":"2016","unstructured":"B\u00fcchsel M, Pletschen L, Fleiner M, H\u00e4cker G, Serr A. A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards ciprofloxacin and clarithromycin in a patient with chronic lymphatic leukemia. Diagn Microbiol Infect Dis. 2016;86(1):115\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"627_CR78","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/cix296","volume":"65","author":"M Thoendel","year":"2017","unstructured":"Thoendel M, Jeraldo P, Greenwood-Quaintance KE, Chia N, Abdel MP, Steckelberg JM, Osmon DR, Patel R. A novel prosthetic joint infection pathogen, Mycoplasma salivarium, identified by metagenomic shotgun sequencing. Clin Infect Dis. 2017;65(2):332\u20135.","journal-title":"Clin Infect Dis"},{"key":"627_CR79","doi-asserted-by":"crossref","unstructured":"Totten AH, Xiao L, Crabb DM, Ratliff AE, Waites KB, Hwangpo T, Atkinson TP. Septic polyarthritis with Mycoplasma salivarium in a patient with common variable immunodeficiency: case report and review of the literature. Access Microbiol 2021, 3(4).","DOI":"10.1099\/acmi.0.000221"},{"key":"627_CR80","doi-asserted-by":"crossref","unstructured":"Beeton ML, Spiller OB. Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? J Antimicrob Chemother 2016:dkw425.","DOI":"10.1093\/jac\/dkw425"},{"issue":"10","key":"627_CR81","first-page":"e01104","volume":"61","author":"MA Valentine-King","year":"2017","unstructured":"Valentine-King MA, Brown MB. Antibacterial resistance in Ureaplasma species and Mycoplasma hominis isolates from urine cultures in college-aged females. Antimicrob Agents Chemother. 2017;61(10):e01104\u201301117.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"627_CR82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.00889-15","volume":"60","author":"ML Beeton","year":"2016","unstructured":"Beeton ML, Chalker VJ, Jones LC, Maxwell NC, Spiller OB. Antibiotic resistance among clinical Ureaplasma isolates recovered from neonates in England and Wales between 2007 and 2013. Antimicrob Agents Chemother. 2016;60(1):52\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"627_CR83","doi-asserted-by":"crossref","first-page":"e22211","DOI":"10.1002\/jcla.22211","volume":"32","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Hua C, Li S. The relationship between the biovars and the antimicrobial resistance of Ureaplasma urealyticum in female patients with urogenital infections. J Clin Lab Anal. 2018;32(1):e22211.","journal-title":"J Clin Lab Anal"},{"key":"627_CR84","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12013-013-9691-8","volume":"68","author":"G Ye","year":"2014","unstructured":"Ye G, Jiang Z, Wang M, Huang J, Jin G, Lu S. The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem Biophys. 2014;68:207\u201310.","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"627_CR85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijantimicag.2009.04.015","volume":"34","author":"E Vlieghe","year":"2009","unstructured":"Vlieghe E, Phoba M, Tamfun JM, Jacobs J. Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008. Int J Antimicrob Agents. 2009;34(4):295\u2013303.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"627_CR86","doi-asserted-by":"crossref","first-page":"e0212131","DOI":"10.1371\/journal.pone.0212131","volume":"14","author":"FK Wangai","year":"2019","unstructured":"Wangai FK, Masika MM, Lule GN, Karari EM, Maritim MC, Jaoko WG, Museve B, Kuria A. Bridging antimicrobial resistance knowledge gaps: the east african perspective on a global problem. PLoS ONE. 2019;14(2):e0212131.","journal-title":"PLoS ONE"},{"issue":"4","key":"627_CR87","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.4314\/ahs.v18i4.41","volume":"18","author":"W Mansour","year":"2018","unstructured":"Mansour W. Tunisian antibiotic resistance problems: three contexts but one health. Afr Health Sci. 2018;18(4):1202\u20133.","journal-title":"Afr Health Sci"},{"issue":"7","key":"627_CR88","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00006454-200107000-00008","volume":"20","author":"S O\u2019CONNOR","year":"2001","unstructured":"O\u2019CONNOR S, Rifkin D, Yang Y-H, Wang J-F, Levine OS, Dowell SF. Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs. Pediatr Infect Dis J. 2001;20(7):679\u201384.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00627-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T13:18:20Z","timestamp":1700313500000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00627-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00627-6","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (this paper was provided based on researching in global databases).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publish"}},{"value":"There is no any conflict of interest among the all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}